A carregar...

GLP-1/glucagon receptor co-agonism for treatment of obesity

Over a relatively short period, obesity and type 2 diabetes have come to represent a large medical and economic burden to global societies. The epidemic rise in the prevalence of obesity has metabolic consequences and is paralleled by an increased occurrence of other diseases, such as diabetes, canc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetologia
Main Authors: Sánchez-Garrido, Miguel A., Brandt, Sara J., Clemmensen, Christoffer, Müller, Timo D., DiMarchi, Richard D., Tschöp, Matthias H.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6448809/
https://ncbi.nlm.nih.gov/pubmed/28733905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-017-4354-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!